EULAR revised recommendations for the management of fibromyalgia
Macfarlane, G J, Kronisch, C, Dean, L E, Atzeni, F, Häuser, W, Fluß, E, Choy, E, Kosek, E, Amris, K, Branco, J, Dincer, F, Leino-Arjas, P, Longley, K, McCarthy, G M, Makri, S, Perrot, S, Sarzi-Puttini, P, Taylor, A, Jones, G T
Published in Annals of the rheumatic diseases (01.02.2017)
Published in Annals of the rheumatic diseases (01.02.2017)
Get full text
Journal Article
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S F, Arendt-Nielsen, S, Bliddal, H, Blotman, F, Branco, J C, Buskila, D, Da Silva, J A P, Danneskiold-Samsøe, B, Dincer, F, Henriksson, C, Henriksson, K G, Kosek, E, Longley, K, McCarthy, G M, Perrot, S, Puszczewicz, M, Sarzi-Puttini, P, Silman, A, Späth, M, Choy, E H
Published in Annals of the rheumatic diseases (01.04.2008)
Published in Annals of the rheumatic diseases (01.04.2008)
Get full text
Journal Article
Fibromyalgia: management strategies for primary care providers
Arnold, L. M., Gebke, K. B., Choy, E. H. S.
Published in International journal of clinical practice (Esher) (01.02.2016)
Published in International journal of clinical practice (Esher) (01.02.2016)
Get full text
Journal Article
Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy
Gujrati, Vipul, Kim, Sunghyun, Kim, Sang-Hyun, Min, Jung Joon, Choy, Hyon E, Kim, Sun Chang, Jon, Sangyong
Published in ACS nano (25.02.2014)
Published in ACS nano (25.02.2014)
Get full text
Journal Article
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
Hoes, J N, Jacobs, J W G, Boers, M, Boumpas, D, Buttgereit, F, Caeyers, N, Choy, E H, Cutolo, M, Da Silva, J A P, Esselens, G, Guillevin, L, Hafstrom, I, Kirwan, J R, Rovensky, J, Russell, A, Saag, K G, Svensson, B, Westhovens, R, Zeidler, H, Bijlsma, J W J
Published in Annals of the rheumatic diseases (01.12.2007)
Published in Annals of the rheumatic diseases (01.12.2007)
Get full text
Journal Article
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
Choy, Ernest, Ganeshalingam, Kandeepan, Semb, Anne Grete, Szekanecz, Zoltán, Nurmohamed, Michael
Published in Rheumatology (Oxford, England) (01.12.2014)
Published in Rheumatology (Oxford, England) (01.12.2014)
Get full text
Journal Article
GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections
Kim, Jin Kyung, Kim, Yi Sak, Lee, Hye-Mi, Jin, Hyo Sun, Neupane, Chiranjivi, Kim, Sup, Lee, Sang-Hee, Min, Jung-Joon, Sasai, Miwa, Jeong, Jae-Ho, Choe, Seong-Kyu, Kim, Jin-Man, Yamamoto, Masahiro, Choy, Hyon E, Park, Jin Bong, Jo, Eun-Kyeong
Published in Nature communications (10.10.2018)
Published in Nature communications (10.10.2018)
Get full text
Journal Article
Fatigue in rheumatoid arthritis reflects pain, not disease activity
Pollard, L. C., Choy, E. H., Gonzalez, J., Khoshaba, B., Scott, D. L.
Published in Rheumatology (Oxford, England) (01.07.2006)
Published in Rheumatology (Oxford, England) (01.07.2006)
Get full text
Journal Article
The hepcidin-ferroportin axis controls the iron content of Salmonella-containing vacuoles in macrophages
Lim, Daejin, Kim, Kwang Soo, Jeong, Jae-Ho, Marques, Oriana, Kim, Hyun-Ju, Song, Miryoung, Lee, Tae-Hoon, Kim, Jae Il, Choi, Hueng-Sik, Min, Jung-Joon, Bumann, Dirk, Muckenthaler, Martina U, Choy, Hyon E
Published in Nature communications (29.05.2018)
Published in Nature communications (29.05.2018)
Get full text
Journal Article
POS0346 THE THERAPEUTIC EFFECTS OF OMEGA-6 PUFA (PINOLENIC ACID) ON THE TRANSCRIPTOMIC PROFILE OF ACTIVATED PERIPHERAL BLOOD MONONUCLEAR CELLS ISOLATED FROM HEALTHY CONTROLS AND RHEUMATOID ARTHRITIS PATIENTS
Takala, R., Ramji, D., Andrews, R., Zhou, Y., Burston, J., Choy, E.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
Ben-Ami, E., Barysauskas, C.M., von Mehren, M., Heinrich, M.C., Corless, C.L., Butrynski, J.E., Morgan, J.A., Wagner, A.J., Choy, E., Yap, J.T., Van den Abbeele, A.D., Solomon, S.M., Fletcher, J.A., Demetri, G.D., George, S.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article